2 recruiting, 1 completed, 1 unknown. 3 Phase 3, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Recruiting 2, Unknown 1 |
| Phase 1 | 1 | Completed 1 |
Follow this drug Literature Review of OLANZapine 2.5 MG trials Research Report on OLANZapine 2.5 MG
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Olanzapine in the Prevention and Treatment of Anorexia-Cachexia Syndrome in Patients Receiving Neoadjuvant/Preoperative Chemotherapy OLANZapine 2.5 MG - Oncology Patients Receiving Chemotherapy, Cachexia-Anorexia Syndrome | Phase 3 | Recruiting | Blokhin's Russian Cancer Research Center | 100 | 2025-03-28 | 2026-06-08 |
| Survival With Olanzapine in Patients With Locally Advanced or Metastatic Upper Gastrointestinal and Lung Cancer Olanzapine 2.5 MG, Standard anti-tumor treatment, Nutritional advice - Advanced Cancer, Olanzapine | Phase 3 | Recruiting | Qinghai Red Cross Hospital | 230 | 2024-03-20 | 2024-03-29 |
| Olanzapine for Cancer Related Anorexia-cachexia Syndrome Olanzapine 2.5 MG, Olanzapine 5 MG, Placebo - Anorexia, Cachexia | Phase 3 | Unknown | Mahidol University | 138 | 2024-01-22 | 2024-07-24 |
| Intranasal Insulin and Olanzapine Study in Healthy Volunteers OLANZapine 2.5 MG, Placebo, Insulin Lispro 100 UNT/ML - Healthy Controls | Phase 1 | Completed | Centre for Addiction and Mental Health | 46 | 2019-10-22 | 2026-10-19 |
Anorexia (1) · Cachexia (1) · Neoplasms (1)
Blokhin's Russian Cancer Research Center (1) · Centre for Addiction and Mental Health (1) · Mahidol University (1) · Qinghai Red Cross Hospital (1)
Canada (1) · China (1) · Russia (1) · Thailand (1)
Margaret K Hahn, PhD, MD (1) · Satya Dash, MD, PhD (1)